Biomerica Receives CE mark for New High-Volume Version of 10 Minute Test for COVID-19 Exposure and Expands International Distribution
07 mai 2020 06h36 HE
|
Biomerica, Inc.
New high-volume production test allows Biomerica to expand international distribution to better meet demand of its 10-minute test for coronavirus exposure. The test can be performed anywhere by...
Biomerica Announces Third Quarter Financial Results
15 avr. 2020 08h30 HE
|
Biomerica, Inc.
IRVINE, Calif., April 15, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $3,967,712 for the nine months ending February 29, 2020, compared to $4,034,822 for the...
Biomerica Signs Two Definitive Agreements with Mount Sinai Medical School in New York to Scale-up a Laboratory Version Serological Test for COVID-19 That Enables High-Volume Screenings in Labs
02 avr. 2020 07h38 HE
|
Biomerica, Inc.
Price point of this high-volume laboratory version test is expected be as low as $10 per patient Once developed and scaled-up, Biomerica’s existing production capacity could allow for over 1,000,000...
Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure
17 mars 2020 20h16 HE
|
Biomerica, Inc.
10-minute test for coronavirus exposure utilizing blood from a finger prick can be performed anywhere by trained professionals, e.g. airports, schools, work, doctor’s office Biomerica has begun...
Biomerica Announces $2.0 Million Investment by Palm Global Small Cap Master Fund
26 févr. 2020 16h41 HE
|
Biomerica, Inc.
IRVINE, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) (the “Company” or “Biomerica”) announced today that the Company completed a private placement of $2 million of...
Biomerica Announces Second Quarter Financial Results; Sales Up 6.4% for the Quarter
15 janv. 2020 08h19 HE
|
Biomerica, Inc.
IRVINE, Calif., Jan. 15, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $1,596,408 for the three months ended November 30, 2019, compared to $1,500,791 for the...
Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica’s InFoods® Irritable Bowel Syndrome (IBS) diagnostic guided therapy clinical trial
07 janv. 2020 08h19 HE
|
Biomerica, Inc.
Texas Medical Center is the largest medical complex in the world with 10 million patient encounters per year and a 1,345-acre campus (50 million square feet of developed facilities)InFoods® Diagnostic...
Biomerica Reports 1st Quarter Fiscal 2020 Financials
16 oct. 2019 08h19 HE
|
Biomerica, Inc.
IRVINE, Calif., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $1,194,415 for the three months ending August 31, 2019, compared to $1,272,870 for the...
Biomerica Announces Fiscal Year End 2019 Financial Results
30 août 2019 08h30 HE
|
Biomerica, Inc.
IRVINE, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported net sales for the fiscal year 2019 were $5,200,682...
Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia
21 août 2019 08h19 HE
|
Biomerica, Inc.
IRVINE, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced the Republic of Colombia Ministry of Health and Social Protection Institute National Surveillance of Drugs...